生物活性 | |||
---|---|---|---|
描述 | Protein kinase C, a family of related serine/threonine kinases implicated in multiple signal transduction pathways, exhibits antitumor property in mammalian cells. D-erythro-Sphingosine is a PKC inhibitor with an EC50 value of 8 ± 3 μM for p32. Treatment of Jurkat T cells with D-erythro-Sphingosine led to a ~4-fold increase in p32 phosphorylation, with the maximal effect observed at 10 μM[1]. D-erythro-Sphingosine is also a PP2A agonist that activates PP2A in neuronal cultures at a concentration of 10 nM. Rats treated with D-erythro-Sphingosine (1 μM) showed a higher locomotor BBB score after spinal cord injury compared to the vehicle-treated control group[2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.34mL 0.67mL 0.33mL |
16.69mL 3.34mL 1.67mL |
33.39mL 6.68mL 3.34mL |
参考文献 |
---|